192 related articles for article (PubMed ID: 18922643)
21. Standardization of the body surface area (BSA) formula to calculate the dose of anticancer agents in Japan.
Kouno T; Katsumata N; Mukai H; Ando M; Watanabe T
Jpn J Clin Oncol; 2003 Jun; 33(6):309-13. PubMed ID: 12913086
[TBL] [Abstract][Full Text] [Related]
22. Body surface area in normal-weight, overweight, and obese adults. A comparison study.
Verbraecken J; Van de Heyning P; De Backer W; Van Gaal L
Metabolism; 2006 Apr; 55(4):515-24. PubMed ID: 16546483
[TBL] [Abstract][Full Text] [Related]
23. Chemotherapy dose intensity and quality cancer care.
Lyman GH
Oncology (Williston Park); 2006 Dec; 20(14 Suppl 9):16-25. PubMed ID: 17370925
[TBL] [Abstract][Full Text] [Related]
24. Chemotherapy dosing part I: scientific basis for current practice and use of body surface area.
Kaestner SA; Sewell GJ
Clin Oncol (R Coll Radiol); 2007 Feb; 19(1):23-37. PubMed ID: 17305252
[TBL] [Abstract][Full Text] [Related]
25. Unfractionated heparin dosing for venous thromboembolism in morbidly obese patients: case report and review of the literature.
Myzienski AE; Lutz MF; Smythe MA
Pharmacotherapy; 2010 Mar; 30(3):324. PubMed ID: 20180615
[TBL] [Abstract][Full Text] [Related]
26. Outcomes in obese and overweight acute myeloid leukemia patients receiving chemotherapy dosed according to actual body weight.
Wenzell CM; Gallagher EM; Earl M; Yeh JY; Kusick KN; Advani AS; Kalaycio ME; Mukherjee S; Tiu RV; Maciejewski JP; Sekeres MA
Am J Hematol; 2013 Oct; 88(10):906-9. PubMed ID: 23828018
[TBL] [Abstract][Full Text] [Related]
27. Vancomycin dosing in children and young adults: back to the drawing board.
Camaione L; Elliott K; Mitchell-Van Steele A; Lomaestro B; Pai MP
Pharmacotherapy; 2013 Dec; 33(12):1278-87. PubMed ID: 24019205
[TBL] [Abstract][Full Text] [Related]
28. A review of body composition and pharmacokinetics in oncology.
Hopkins JJ; Sawyer MB
Expert Rev Clin Pharmacol; 2017 Sep; 10(9):947-956. PubMed ID: 28649898
[TBL] [Abstract][Full Text] [Related]
29. Extremely high exposures in an obese patient receiving high-dose cyclophosphamide, thiotepa and carboplatin.
De Jonge ME; Mathôt RA; Van Dam SM; Beijnen JH; Rodenhuis S
Cancer Chemother Pharmacol; 2002 Sep; 50(3):251-5. PubMed ID: 12203108
[TBL] [Abstract][Full Text] [Related]
30. Dosing of antibacterial agents in obese adults: does one size fit all?
Payne KD; Hall RG
Expert Rev Anti Infect Ther; 2014 Jul; 12(7):829-54. PubMed ID: 24809811
[TBL] [Abstract][Full Text] [Related]
31. A cross-sectional study comparing variation in body surface area and chemotherapy dosing in pediatric oncology using two different methods.
Jastaniah W; Aseeri M
J Oncol Pharm Pract; 2010 Sep; 16(3):189-93. PubMed ID: 19808711
[TBL] [Abstract][Full Text] [Related]
32. Tolerability of induction chemotherapy dosing practices in acute myeloid leukemia patients.
Peric KM; Reeves DJ
Leuk Res; 2015 Feb; 39(2):173-6. PubMed ID: 25542696
[TBL] [Abstract][Full Text] [Related]
33. [Use of body weight and body surface area in dosing of anticancer agents in adult patients].
Levêque D
Bull Cancer; 2007 Jul; 94(7):647-51. PubMed ID: 17723945
[TBL] [Abstract][Full Text] [Related]
34. [A case of acute myeloid leukemia in an obese patient--determining the therapeutic dose of anticancer drugs].
Kawaguchi Y; Inagaki A; Sato Y; Ogura H; Wakita A
Gan To Kagaku Ryoho; 2014 Dec; 41(13):2603-5. PubMed ID: 25596056
[TBL] [Abstract][Full Text] [Related]
35. New Perspectives on an Old Friend: Optimizing Carboplatin for the Treatment of Solid Tumors.
Alberts DS; Dorr RT
Oncologist; 1998; 3(1):15-34. PubMed ID: 10388081
[TBL] [Abstract][Full Text] [Related]
36. Toxic effect of chemotherapy dosing using actual body weight in obese versus normal-weight patients: a systematic review and meta-analysis.
Hourdequin KC; Schpero WL; McKenna DR; Piazik BL; Larson RJ
Ann Oncol; 2013 Dec; 24(12):2952-62. PubMed ID: 23965736
[TBL] [Abstract][Full Text] [Related]
37. Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative.
Gurney H
J Clin Oncol; 1996 Sep; 14(9):2590-611. PubMed ID: 8823340
[TBL] [Abstract][Full Text] [Related]
38. The effects of age and chemotherapy on gentamicin pharmacokinetics and dosing in pediatric oncology patients.
Ho KK; Bryson SM; Thiessen JJ; Greenberg ML; Einarson TR; Leson CL
Pharmacotherapy; 1995; 15(6):754-64. PubMed ID: 8602384
[TBL] [Abstract][Full Text] [Related]
39. Inter- and intrapatient variability in oral topotecan pharmacokinetics: implications for body-surface area dosage regimens.
Loos WJ; Gelderblom H; Sparreboom A; Verweij J; de Jonge MJ
Clin Cancer Res; 2000 Jul; 6(7):2685-9. PubMed ID: 10914710
[TBL] [Abstract][Full Text] [Related]
40. Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114.
Meyerhardt JA; Tepper JE; Niedzwiecki D; Hollis DR; McCollum AD; Brady D; O'Connell MJ; Mayer RJ; Cummings B; Willett C; Macdonald JS; Benson AB; Fuchs CS
J Clin Oncol; 2004 Feb; 22(4):648-57. PubMed ID: 14966087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
